{"id":1564,"date":"2021-06-17T20:18:48","date_gmt":"2021-06-17T20:18:48","guid":{"rendered":"https:\/\/staging.interamericancoalition-medtech.org\/regulatory-convergence\/respuesta-de-estados-unidos-de-america\/"},"modified":"2021-07-08T18:56:48","modified_gmt":"2021-07-08T18:56:48","slug":"united-states-of-america-response","status":"publish","type":"page","link":"https:\/\/staging.interamericancoalition-medtech.org\/regulatory-convergence\/covid-19\/united-states-of-america-response\/?lang=es","title":{"rendered":"Respuesta de Estados Unidos de Am\u00e9rica"},"content":{"rendered":"\n

En esta p\u00e1gina encontrar\u00e1 recursos \u00fatiles producidos por la USFDA y AdvaMed.<\/p>\n\n\n\n

\n
<\/a>
<\/path><\/svg><\/span><\/span>
Recursos de FDA\/CDRH COVID-19, en idioma ingl\u00e9s.<\/span><\/div><\/div><\/div>\n<\/div><\/div>\n\n\n\n

AdvaMed en idioma ingl\u00e9s:<\/p>\n\n\n\n

\n
<\/a>
<\/path><\/svg><\/span><\/span>
Pruebas de Diagn\u00f3stico In Vitro<\/em> de COVID-19: Apoyando el Cuidado del Paciente y Protegiendo la Salud P\u00fablica<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
Centro de recursos de tecnolog\u00eda m\u00e9dica COVID-19<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
Principios de COVID-19 de AdvaMed<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
Kit de herramientas de informaci\u00f3n COVID-19<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
Pruebas de diagn\u00f3stico In Vitro<\/em> de COVID-19<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
Gu\u00eda de cumplimiento del C\u00f3digo de \u00c9tica relacionada con la respuesta al COVID-19<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
Reanudaci\u00f3n segura de cirug\u00edas<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
PRINCIPIOS PARA LA PREPARACI\u00d3N: El plan de la industria de tecnolog\u00eda m\u00e9dica para responder a una crisis extraordinaria de atenci\u00f3n m\u00e9dica<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
PRINCIPIOS PARA LA PREPARACI\u00d3N: Resumen Ejecutivo<\/span><\/div><\/div><\/div>\n\n\n\n
<\/a>
<\/path><\/svg><\/span><\/span>
Consideraciones globales<\/span><\/div><\/div><\/div>\n<\/div><\/div>\n\n\n\n
<\/div>
\n

REGULATORY COALITION PRINCIPAL MEMBERS<\/h3>\n\n\n